Home › Calculator › NMTRQ Dividend Calculator 2026
NMTRQ Dividend Calculator 2026
No dividendHealthcare9 Meters Biopharma, Inc. · OTC
Price: $0.00 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
NMTRQ is not a dividend-focused stock
NMTRQ pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
NMTRQ Dividend Yield
9 Meters Biopharma, Inc. (NMTRQ) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NMTRQ pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About 9 Meters Biopharma, Inc. (NMTRQ) — Dividend Analysis 2026
Operating as a clinical-stage biopharmaceutical firm, 9 Meters Biopharma, Inc. specialized in creating therapies for individuals in North America afflicted by rare digestive illnesses, various gastrointestinal disorders lacking effective treatments, and other debilitating conditions. Its primary therapeutic candidate was Vurolenatide, a long-acting injectable glucagon-like peptide-1, which had advanced to Phase 3 clinical trials for the management of short bowel syndrome. The company's pipeline also included NM-136, a humanized monoclonal antibody aimed at treating obesity and associated conditions; NM-102, a small molecule peptide designed to hinder antigen entry into the systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist intended to prevent acute graft versus host disease. Furthermore, it partnered on Larazotide, an 8-amino acid peptide undergoing Phase 2 clinical trials for multi-system inflammatory syndrome. Licensing arrangements were established with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. Headquartered in Raleigh, North Carolina, 9 Meters Biopharma, Inc. initiated a voluntary petition for liquidation under Chapter 7 of the U.S. Bankruptcy Code on July 17, 2023, in the U.S. Bankruptcy Court for the Eastern District of North Carolina.
NMTRQ Dividend & DRIP — Frequently Asked Questions
Does NMTRQ pay a dividend?
No. 9 Meters Biopharma, Inc. (NMTRQ) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of NMTRQ?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does NMTRQ have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. NMTRQ has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to NMTRQ
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NMTRQ DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NMTRQ position with:
🌍 NMTRQ Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NMTRQ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NMTRQ Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NMTRQ Dividend Payment Schedule
NMTRQ pays quarterly — 4 times per year. Ex-div: —.
📊 NMTRQ vs Healthcare Benchmarks
How NMTRQ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NMTRQ sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NMTRQ Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare NMTRQ with peers: NMTRQ vs ACBM · NMTRQ vs ALLO · NMTRQ vs BEAM
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NMTRQ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
9 Meters Biopharma, Inc. (NMTRQ) is currently trading at $0.00, 80% below its 52-week high. It does not currently pay a regular dividend.
Does NMTRQ Pay a Dividend? 9 Meters Biopharma, Inc. Dividend Status
9 Meters Biopharma, Inc. (NMTRQ) is a healthcare stock trading at $0.00. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest NMTRQ News
LiveProjected your NMTRQ DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.